• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉搏动指数作为非酒精性脂肪性肝病分期的无创工具:一项病例对照研究

Portal Vein Pulsatility Index as a Noninvasive Tool for Staging Nonalcoholic Fatty Liver Disease: A Case-Control Study.

作者信息

Mohan Sravya, Sakalecha Anil K, A Raveesha, Krishnan Jagannathan, S N Rashmi

机构信息

Radiodiagnosis, Sri Devaraj Urs Medical College, Kolar, IND.

General Medicine, Sri Devaraj Urs Medical College, Kolar, IND.

出版信息

Cureus. 2025 Aug 18;17(8):e90377. doi: 10.7759/cureus.90377. eCollection 2025 Aug.

DOI:10.7759/cureus.90377
PMID:40970074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12442140/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) causes progressive liver fibrosis and vascular remodeling. Portal vein pulsatility index (PVPI) has emerged as a potential ultrasound biomarker for high-risk NAFLD, but its relationship to other Doppler measures is not fully explored.

PURPOSE

To evaluate PVPI as a noninvasive tool for staging NAFLD and to incorporate portal vein resistive index (RI) and peak systolic velocity (PSV) parameters for a more comprehensive assessment of hepatic vascular resistance.

METHODS

We performed a case-control study of NAFLD patients (spanning mild steatosis to advanced fibrosis) and healthy controls. All subjects underwent duplex Doppler ultrasound. PVPI was calculated as [(Vmax - Vmin)/Vmean]. Simulated portal RI and PSV values for each NAFLD severity group were also derived. Key outcomes were compared across steatosis grades and fibrosis categories and correlated with fibrosis risk scores.

RESULTS

NAFLD patients had significantly lower PVPI than controls (p < 0.001), and PVPI decreased progressively with higher steatosis grade and fibrosis stage. High-risk NAFLD (significant fibrosis) showed a markedly reduced PVPI (mean ~0.20 vs. ~0.30 in low-risk) alongside a decline in portal RI and PSV. For example, portal PSV dropped from ~13 cm/s in mild NAFLD to ~10 cm/s in advanced fibrosis. PVPI correlated with fibrosis stage (r ~ -0.44), and adding RI/PSV helped delineate increases in hepatic vascular resistance.

CONCLUSION

Portal vein Doppler indices (PVPI, RI, PSV) worsen with NAFLD severity. PVPI, especially when complemented by RI and PSV, is a promising noninvasive marker for staging NAFLD and identifying high-fibrosis risk.

摘要

背景

非酒精性脂肪性肝病(NAFLD)会导致进行性肝纤维化和血管重塑。门静脉搏动指数(PVPI)已成为高危NAFLD的一种潜在超声生物标志物,但其与其他多普勒测量指标的关系尚未得到充分探索。

目的

评估PVPI作为NAFLD分期的非侵入性工具,并纳入门静脉阻力指数(RI)和收缩期峰值流速(PSV)参数,以更全面地评估肝血管阻力。

方法

我们对NAFLD患者(涵盖轻度脂肪变性至晚期纤维化)和健康对照进行了一项病例对照研究。所有受试者均接受了双功多普勒超声检查。PVPI计算为[(Vmax - Vmin)/Vmean]。还得出了每个NAFLD严重程度组的模拟门静脉RI和PSV值。对不同脂肪变性等级和纤维化类别之间的关键结果进行了比较,并与纤维化风险评分相关联。

结果

NAFLD患者的PVPI显著低于对照组(p < 0.001),并且PVPI随着脂肪变性等级和纤维化阶段的升高而逐渐降低。高危NAFLD(显著纤维化)显示PVPI明显降低(平均约0.20,而低风险组约为0.30),同时门静脉RI和PSV下降。例如,门静脉PSV从轻度NAFLD时的约13 cm/s降至晚期纤维化时的约10 cm/s。PVPI与纤维化阶段相关(r约为 -0.44),并且添加RI/PSV有助于描绘肝血管阻力的增加。

结论

门静脉多普勒指标(PVPI、RI、PSV)随NAFLD严重程度加重而恶化。PVPI,尤其是在辅以RI和PSV时,是一种有前景的用于NAFLD分期和识别高纤维化风险的非侵入性标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7c/12442140/427ee6c3618f/cureus-0017-00000090377-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7c/12442140/4b301edb4a9e/cureus-0017-00000090377-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7c/12442140/ae5c77de1ccd/cureus-0017-00000090377-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7c/12442140/427ee6c3618f/cureus-0017-00000090377-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7c/12442140/4b301edb4a9e/cureus-0017-00000090377-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7c/12442140/ae5c77de1ccd/cureus-0017-00000090377-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7c/12442140/427ee6c3618f/cureus-0017-00000090377-i03.jpg

相似文献

1
Portal Vein Pulsatility Index as a Noninvasive Tool for Staging Nonalcoholic Fatty Liver Disease: A Case-Control Study.门静脉搏动指数作为非酒精性脂肪性肝病分期的无创工具:一项病例对照研究
Cureus. 2025 Aug 18;17(8):e90377. doi: 10.7759/cureus.90377. eCollection 2025 Aug.
2
The correlation between metabolic dysfunction-associated steatotic liver disease (MASLD) grades and hemodynamic alterations of the portal, hepatic, and splenic vein and spleen size.代谢功能障碍相关脂肪性肝病(MASLD)分级与门静脉、肝静脉、脾静脉血流动力学改变及脾脏大小之间的相关性。
J Ultrasound. 2024 Nov 13. doi: 10.1007/s40477-024-00965-x.
3
A Validation Study of Non-invasive Scoring Systems for Assessing Severity of Hepatic Fibrosis in a Cohort of South Indian Patients With Non-alcoholic Fatty Liver Disease.一项针对南印度非酒精性脂肪性肝病患者队列评估肝纤维化严重程度的非侵入性评分系统的验证研究。
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101407. doi: 10.1016/j.jceh.2024.101407. Epub 2024 Apr 5.
4
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.超声检查在酒精性肝病患者中对酒精性肝硬化的诊断作用
Cochrane Database Syst Rev. 2016 Mar 2;3(3):CD011602. doi: 10.1002/14651858.CD011602.pub2.
5
Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.磁共振成像质子密度脂肪分数与非酒精性脂肪性肝病或非酒精性脂肪性肝炎患者肝脏组织学特征的相关性。
Gastroenterology. 2018 Nov;155(5):1428-1435.e2. doi: 10.1053/j.gastro.2018.07.018. Epub 2018 Jul 19.
6
The Onset of Steatosis Occurs as Early as Seven Days and Progresses to Nonalcoholic Steatohepatitis in a Pediatric Pig Model of Nonalcoholic Fatty Liver Disease.在非酒精性脂肪性肝病的小儿猪模型中,脂肪变性早在七天时就已出现,并进展为非酒精性脂肪性肝炎。
J Nutr. 2025 Jan;155(1):211-223. doi: 10.1016/j.tjnut.2024.11.009. Epub 2024 Nov 12.
7
Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada.突破界限:解析印度和加拿大儿童中与代谢功能障碍相关的脂肪性肝病
Can Liver J. 2024 Feb 26;7(3):327-337. doi: 10.3138/canlivj-2023-0023. eCollection 2024 Aug.
8
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.